Log In |  View Cart |  Contact
Home Dr. Dharma's Bio Supplements Sale/Bundles Books/DVD
Are Your Memories Fading?
The Memory Caps are specifically created to help to support memory function, stop memory loss, and to eliminate dangerous toxins from your brain.

Boost your brain energy, increase the concentration of the all-important brain chemical acetylcholine, and dissolve brain-cell-killing free radicals. The Memory Caps also contain a patented formula to block the dangerous effects of stress on your brain and boost your energy.

Don’t delay. Avoid irreversible memory damage before it’s too late.
Only $44.95!
Brain Caps
Supplement Facts  References
Have questions or need help
choosing the right supplements?
Contact Valerie at
Mon-Fri 9 AM - 5 PM MST
For faster service, send us a message here

Sign Up for Dr. Dharma's Newsletter

Is Your Memory Fading?

The latest emerging scientific research reveals that the toxins in our air (Aluminum, Cadmium, Mercury, Lead); in our water (Chlorine, Fluoride, Copper); and even in our food (Pesticides, Fungicides, Herbicides), may stick in our brain and ruin our memory.

These toxins, if allowed to stay in your brain, can poison it and lead to irreversible memory problems, including Alzheimer’s disease.

In addition, the ingredients in the Memory Caps have been clinically proven to improve symptoms of Subjective Cognitive Decline (SCD), Mild Cognitive Impairment (MCI) and Early Alzheimer’s disease.

That’s why I’m urging you to take Memory Caps.

The Benefits of the Memory Caps:

  • Eliminate the toxins in your brain
  • Support Your memory Function
  • Make your brain younger
  • Increase brain energy
  • Improve the levels of important memory chemicals in your brain, such as Acetylcholine.

Don’t delay. Avoid irreversible memory damage before it’s too late.

Get rid of brain toxins and maximize your memory function now.

“Dr. Dharma: You have helped my husband Jeffrey maintain his memory even though he has early Alzheimer’s. The Memory Caps are a God-send.” Edna S, Retired 73 years old Social Worker, Detroit, MI”
~ Edna S., Retired 73 years old Social Worker, Detroit, MI.


Read More About the Memory Caps:



Memory Caps - Supplement Facts


Memory Caps




  1. Adams JD Jr, Yang J, Mishra LC, Singh BB. Effects of ashwagandha in a rat model of stroke. Altern Ther Health Med. 2002 Sep-Oct;8(5):18-9.
  2. Agarwal R, Diwanay S, Patki P, Patwardhan B. Studies on immunomodulatory activity of Withania somnifera (Ashwagandha) extracts in experimental immune inflammation. J Ethnopharmacol. 1999 Oct;67(1):27-35.
  3. Bhattacharya SK, Bhattacharya A, Sairam K, Ghosal S. Anxiolytic-antidepressant activity of Withania somnifera glycowithanolides: an experimental study. Phytomedicine. 2000 Dec;7(6):463-9.
  4. Dhuley JN. Effect of ashwagandha on lipid peroxidation in stress-induced animals. J Ethnopharmacol. 1998 Mar;60(2):173-8. 9.
  5. Dhuley JN. Nootropic-like effect of ashwagandha (Withania somnifera L.) in mice. Phytother Res. 2001 Sep;15(6):524-8.
  6. Kuboyama T, Tohda C, Komatsu K. Withanoside IV and its active metabolite, sominone, attenuate Abeta(25-35)-induced neurodegeneration. Eur J Neurosci. 2006 Mar;23(6):1417-26.
  7. Kuboyama T, Tohda C, Komatsu K. Neuritic regeneration and synaptic reconstruction induced by withanolide A. Br J Pharmacol. 2005 Apr;144(7):961-71.
  8. Kulkarni RR, Patki PS, Jog VP, et al. Treatment of osteoarthritis with a herbomineral formulation: a double-blind, placebo-controlled, cross-over study. J Ethnopharmacol 1991;33:91-95.
  9. Mishra, LK, Singh, BB. Scientific Basis for the therapeutic use of Withania somnifer (Ashwagandha): A Review. Alt Med Review 2000 vol 5; no 4; 334-346.
  10. Panda S, Kar A. Evidence for free radical scavenging activity of Ashwagandha root powder in mice. Indian J Physiol Pharmacol. 1997 Oct;41(4):424-6.
  11. Singh B, Gupta DK, Chandan BK. Adaptogenic activity of a glyco-peptido-lipid fraction from the alcoholic extract of Trichopus zeylanicus Gaertn. Phytomedicine. 2001 Jul;8(4):283-91.
  12. Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B. Studies on the immunomodulatory effects of Ashwagandha. J Ethnopharmacol. 1996 Feb;50(2):69-76.
  13. Tohda C, Kuboyama T, Komatsu K. Search for natural products related to regeneration of the neuronal network. Neurosignals. 2005;14(1-2):34-45.
  14. Ziauddin M, Phansalkar N, Patki P, Diwanay S, Patwardhan B. Studies on the immunomodulatory effects of Ashwagandha. J Ethnopharmacol. 1996 Feb;50(2):69-76.


  1. Bickford PC, Gould T, Briederick L, et al. Antioxidant-rich diets improve cerebellar physiology and motor learning in aged rats. Brain Res 2000;866:211-7.
  2. Bomser J, Madhavi DL, Singletary K, Smith MA. In vitro anticancer activity of fruit extracts from Vaccinium species. Planta Med 1996;62:212-6.
  3. Cao G, Shukitt-Hale B, Bickford PC, et al. Hyperoxia-induced changes in antioxidant capacity and the effect of dietary antioxidants. J Appl Physiol 1999;86:1817-22.
  4. Cignarella A, Nastasi M, Cavalli E, Puglisi L. Novel lipid-lowering properties of Vaccinium myrtillus L. leaves, a traditional antidiabetic treatment, in several models of rat dyslipidaemia: a comparison with ciprofibrate. Thromb Res 1996;84:311-22.
  5. Hiraishi K, Narabayashi I, Fujita O, et al. Blueberry juice: preliminary evaluation as an oral contrast agent in gastrointestinal MR imaging. Radiology 1995;194:119-23.
  6. Howell AB, Vorsa N, Foo LY, et al. Inhibition of the Adherence of P-Fimbriated Escherichia coli to Uroepithelial-Cell Surfaces by Proanthocyanidin Extracts from Cranberries (letter). N Engl J Med 1998;339:1085-6.
  7. Joseph JA, Denisova N, Fisher D, et al. Membrane and receptor modifications of oxidative stress vulnerability in aging. Nutritional considerations. Ann N Y Acad Sci 1998;854:268-76.
  8. Joseph JA, Shukitt-Hale B, Denisova NA, et al. Reversals of age-related declines in neuronal signal transduction, cognitive, and motor behavioral deficits with blueberry, spinach, or strawberry dietary supplementation. J Neurosci 1999;19:8114-21.
  9. Lyons MM, Yu C, Toma RB, et al. Resveratrol in raw and baked blueberries and bilberries. J Agric Food Chem 2003;51:5867-70.
  10. Ofek I, Goldhar J, Zafriri D, et al. Anti-Escherichia coli adhesin activity of cranberry and blueberry juices. N Engl J Med 1991;324:1599.
  11. Wang SY, Jiao H. Scavenging capacity of berry crops on superoxide radicals, hydrogen peroxide, hydroxyl radicals, and singlet oxygen. J Agric Food Chem 2000;48:5677-84.
  12. Wang SY, Lin HS. Antioxidant activity in fruits and leaves of blackberry, raspberry, and strawberry varies with cultivar and developmental stage. J Agric Food Chem 2000;48:140-6.
  13. Wu X, Cao G, Prior RL. Absorption and metabolism of anthocyanins in elderly women after consumption of elderberry or blueberry. J Nutr 2002;132:1865-71.
  14. Youdim KA, Shukitt-Hale B, MacKinnon S, et al. Polyphenolics enhance red blood cell resistance to oxidative stress: in vitro and in vivo (1). Biochim Biophys Acta 2000;1519:117-22.

Huperzine A

Huperzine A is an extract from a club moss (Huperzia Serrata) and has been used for centuries in China. The primary purpose of huperzine A is to prevent the breakdown of acetylcholine. Acetylcholine is vital to the nervous system for transmitting information between cells.

"Huperzine A appears to bind more tightly and specifically to acetylcholinesterase than the other acetylcholinesterase inhibitors. It is as if this natural substance were ingeniously designed to fit into the exact spot in acetylcholinesterase where it will do the most good.”

~ Professor. Joel Sussman

Huperzine A. Review of Natural Products. Facts & Comparisons [database online]. St. Louis, MO: Wolters Kluwer Health Inc; July 2010.

  1. Skolnick A. Old Chinese herbal medicine used for fever yields possible new Alzheimer disease therapy. JAMA. 1997;277:776.
  2. Sun QQ, Xu SS, Pan JL, et al. Huperzine-A capsules enhance memory and learning performance in 34 pairs of matched adolescent students. Chung Kuo Yao Li Hseuh Pao. 1999;20:601-3.
  3. Pepping J. Huperzine A. Am J Health Syst Pharm. 2000;57:530-4.
  4. Ou LY, Tang XC, Cai JX. Effect of huperzine A on working memory in reserpine- or yohimbine-treated monkeys. Eur J Pharmacol. 2001 Dec 21;433(2-3):151-6.
  5. Filliat P, Foquin A, Lallement G. Effects of chronic administration of huperzine A on memory in guinea pigs. Drug Chem Toxicol. 2002 Feb;25(1):9-24.
  6. Zhang C, Wang SZ, Zuo PP, Cui X, Cai J. Effect of tetramethylpyrazine on learning, memory and cholinergic system in D-galactose-lesioned mice. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2003 Oct;25(5):553-6.
  7. Xu Z, Zheng H, Law SL, et al. Effects of a memory enhancing peptide on cognitive abilities of brain-lesioned mice: additivity with huperzine A and relative potency to tacrine. J Pept Sci. 2006 Jan;12(1):72-8.
  8. Zhang SL. Therapeutic effects of huperzine A on the aged with memory impairment. [Article in Chinese]. New Drugs and Clinical Remedies 1986;5:260-2.
  9. Zhang RW, Tang XC, Han YY, et al. Drug evaluation of huperzine A in the treatment of senile memory disorders. [Article in Chinese]. Chung Kuo Yao Li Hsueh Pao 1991;12:250-2.
    Xu SS, Gao ZX, Weng Z, et al. Efficacy of tablet huperzine-A on memory, cognition, and behavior in Alzheimer's disease. Zhongguo Yao Li Xue Bao 1995;16:391-5.
  10. Xu SS, Cai ZY, Qu ZW, et al. Huperzine-A in capsules and tablets for treating patients with Alzheimer disease. Zhongguo Yao Li Xue Bao 1999;20:486-90.
    Zhang Z, Wang X, Chen Q, et al. Clinical efficacy and safety of huperzine Alpha in treatment of mild to moderate Alzheimer disease, a placebo-controlled, double-blind, randomized trial. Zhonghua Yi Xue Za Zhi. 2002 Jul 25;82(14):941-4.
  11. National Institute on Aging; Georgetown University Medical Center. A multi-center, double-blind, placebo-controlled, therapeutic trial to determine whether natural Huperzine A improves cognitive function. ClinicalTrials.gov. Washington (D.C.): 2008 Feb [cited 2010 Jan 4]. Available from http://clinicaltrials.gov/show/ NCT00083590. NLM Identifier: NCT00083590.
  12. Li J, Wu HM, Zhou RL, et al. Huperzine A for Alzheimer’s disease. Cochrane Database Syst Rev. 2008 Apr 16;(2):CD005592.
  13. Grunwald J, Raveh L, Doctor BP, Ashani Y. Huperzine A as a pretreatment candidate drug against nerve agent toxicity. Life Sci 1994;54:991-7.
  14. Skolnick AA. Old Chinese herbal medicine used for fever yields possible new Alzheimer Disease therapy. JAMA 1997;277:776.
  15. Lallement G, Veyret J, Masqueliez C, et al. Efficacy of huperzine in preventing soman-induced seizures, neuropathological changes and lethality. Fundam Clin Pharmacol 1997;11:387-94.
  16. Lallement G, Veyret J, Masqueliez C, et al. Efficacy of huperzine in preventing soman-induced seizures, neuropathological changes and lethality. Fundam Clin Pharmacol. 1997;11(5):387-94.
  17. Tonduli LS, Testylier G, Masqueliez C, et al. Effects of Huperzine used as pre-treatment against soman-induced seizures. Neurotoxicology. 2001 Feb;22(1):29-37.
  18. Lallement G, Demoncheaux JP, Foquin A, et al. Subchronic administration of pyridostigmine or huperzine to primates: compared efficacy against soman toxicity. Drug Chem Toxicol. 2002 Aug;25(3):309-20.


  1. Abidov M, Grachev S, Seifulla RD, Ziegenfuss TN. Extract of Rhodiola rosea radix reduces the level of C-reactive protein and creatinine kinase in the blood. Bull Exp Biol Med 2004, 138(1):63-4.
  2. Ali Z, Fronczek FR, Khan IA. Phenylalkanoids and monoterpene analogues from the roots of Rhodiola rosea. Planta Med 2008; 74: 178-81.
  3. Aslanyan G, Amroyan E, Gabrielyan E, Nylander M, Wikman G, Panossian A. Double-blind, placebo-controlled, randomised study of single dose effects of ADAPT-232 on cognitive functions. Phytomed 2010, 17(7):494-9.
  4. Battistelli M, De Sanctis R, De Bellis R, Cucchiarini L, Dacha M, Gobbi P. Rhodiola rosea as antioxidant in red blood cells: ultrastructural and haemolytic behaviour. Eur J Histochem 2005, 49(3):243-54.
  5. Blomkvist J, Taube A, Larhammar D. Perspective on Roseroot (Rhodiola rosea) studies. Planta Med 2009, 75(11):1187-90.
  6. Boon-Niermeijer EK, van den Berg A, Wikman G, Wiegant FA. Phyto-adaptogens protect against environmental stress-induced death of embryos from the freshwater snail Lymnaea stagnalis. Phytomed 2000, 7(5):389-99.
  7. Bystritsky A, Kerwin L, Feusner JD. A pilot study of Rhodiola rosea (Rhodax) for generalized anxiety disorder (GAD). J Altern Complement Med 2008, 14(2):175-80.
  8. Calcabrini C, De Bellis R, Mancini U, Cucchiarini L, Potenza L, De Sanctis R, Patrone V, Scesa C, Dacha M. Rhodiola rosea ability to enrich cellular antioxidant defences of cultured human keratinocytes. Arch Dermatol Res 2010, 302(3):191-200.
  9. Darbinyan V, Kteyan A, Panossian A, Gabrielian E, Wikman G, Wagner H. Rhodiola rosea in stress induced fatigue--a double blind cross-over study of a standardized extract SHR-5 with a repeated low-dose regimen on the mental performance of healthy physicians during night duty. Phytomedicine. 2000 Oct;7(5):365-71.
  10. Kelly GS. Rhodiola rosea: a possible plant adaptogen. Altern Med Rev. 2001 Jun;6(3):293-302.
    Spasov AA, Wikman GK, Mandrikov VB, Mironova IA, Neumoin VV. A double-blind, placebo-controlled pilot study of the stimulating and adaptogenic effect of Rhodiola rosea SHR-5 extract on the fatigue of students caused by stress during an examination period with a repeated low-dose regimen. Phytomedicine. 2000 Apr;7(2):85-9.
  11. Kucinskaite A, Briedis V, Savickas A. [Experimental analysis of therapeutic properties of Rhodiola rosea L. and its possible application in medicine]. Medicina (Kaunas). 2004;40(7):614-
  12. Maslov LN, Lishmanov IuB. Cardioprotective and antiarrhythmic properties of Rhodiolae roseae preparations. Eksp Klin Farmakol. 2007 Sep-Oct;70(5):59-67
  13. Natural Elixir website. Available at http://www.naturalelixir.com/stresscontrol.html. Accessed September 12, 2009.
  14. Panossian A, Wikman G. Evidence-Based Efficacy of Adaptogens in Fatigue, and Molecular Mechanisms Related to Their Stress-Protective Activity. Curr Clin Pharmacol. 2009 Sep 1. [Epub ahead of print]


Vinpocetine is a semi-synthetic derivative of a periwinkle plant extract. Vinpocetine increases blood circulation and metabolism in the brain. Vinpocetine was introduced over 20 years ago in Europe and was originally used in clinical practice to treat cerebrovascular and cognitive disorders. Over 100 clinical studies have revealed vinpocetine to be safe and effective.

  1. Balestreri R, Fontana L, Astengo F. A double-blind placebo controlled evaluation of the safety and efficacy of Vinpocetine in the treatment of patients with chronic vascular senile cerebral dysfunction. J Am Geriatr Soc 1987;35:425-430.
  2. Bereczki D, Fekete I. A systematic review of vinpocetine therapy in acute ischaemic stroke.
  3. Bereczki D, Fekete I. Vinpocetine for acute ischaemic stroke. Cochrane Database Syst Rev. 2008 Jan 23;(1):CD000480. Eur J Clin Pharmacol. 1999;55:349-52.
  4. Bhatti JZ, Hindmarch I. Vinpocetine effects on cognitive impairments produced by flunitrazepam. Int Clin Psychopharmacol. 1987 Oct;2(4):325-31.
  5. Feigin VL, Doronin BM, Popovva TF, et al. Vinpocetine treatment in acute ischaemic stroke: a pilot single-blind randomized clinical trial. Eur J Neurol. 2001;8:81-5.
  6. Fischhof PK, Moslinger-Gehmayr R, Herrmann WM, Friedmann A, Russmann DL. Therapeutic efficacy of vincamine in dementia. Neuropsychobiology 1996;34(1):29-35
  7. Grant JE, Veldee MS, Buchwald D. Analysis of dietary intake and selected nutrient concentrations in patients with chronic fatigue syndrome. J Am Diet Assoc. 1996;96:383-6.
  8. Hindmarch I, Fuchs H, Erzigkeit H. Efficacy and tolerance of Vinpocetine in ambulant patients suffering from mild to moderate organic psychosyndromes. Int Clin Psychopharmacol 1991;6:31-43.
  9. Kiss B, Karpati E. Mechanism of action of vinpocetine. Acta Pharm Hung. 1996 Sep;66(5):213-24. Hungarian.
  10. Konopka W, Zalewski P, Olszewski J, et al.[Treatment results of acoustic trauma.]Otolaryngol Pol. 1997;51 Suppl 25:281-4.
  11. McDaniel MA, Maier SF, Einstein GO. “Brain-specific” nutrients: a memory cure? Nutrition. 2003 Nov-Dec;19(11-12):957-75.
  12. Nicholson CD. Pharmacology of nootropics and metabolically active compounds in relation to their use in dementia. Psychopharmacology (Berl) 1990;101:147- 159.
  13. Otomo E, Atarashi J, Araki G, et al. Comparison of Vinpocetine with ifenprodil tartrate and dihydroergotoxine mesylate treatment and results of long-term treatment with Vinpocetine. Curr Therapeutic Res 1985;37:811-821.
  14. Subhan Z, Hindmarch I. Psycopharmacological effects of vinpocetine in normal healthy volunteers. Eur J Clin Pharmacol. 1985;28(5):567-71.
  15. Szatmari SZ, Whitehouse PJ. Vinpocetine for cognitive impairment and dementia. Cochrane Database Syst Rev. 2003;1:CD003119.
  16. Végh S, Szikszay E, Bonoczk P, Cserjés Z, Kiss G. [Retrospective analysis of the effect of vinpocetine infusion in ophthalmologic disorders.] Orv Hetil. 2006 Dec 10;147(49):2361-5.
  17. Wollschlaeger B. Efficacy of vinpocetine in the management of cognitive impairment and memory loss. JANA. 2001;4:25-30.


Powered by Full Partner